National Research & Development Corp. v. Varian Associates, Inc.

883 F. Supp. 976, 1995 U.S. Dist. LEXIS 6151, 1995 WL 262830
CourtDistrict Court, D. New Jersey
DecidedMay 4, 1995
DocketCiv. A. 89-2459 (HAA)
StatusPublished
Cited by1 cases

This text of 883 F. Supp. 976 (National Research & Development Corp. v. Varian Associates, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
National Research & Development Corp. v. Varian Associates, Inc., 883 F. Supp. 976, 1995 U.S. Dist. LEXIS 6151, 1995 WL 262830 (D.N.J. 1995).

Opinion

OPINION

HAROLD A. ACKERMAN, District Judge.

In 1989, plaintiff, the National Research and Development Corporation (“NRDC” or “plaintiff’) 1 , brought this action for infringement of U.S. Patent No. 3,999,188 (“’118 patent” or “Hoult patent”) against Varían Associates, Inc. (‘Varían” or “defendant”).

The Hoult patent discloses four claims. Claim 1 describes a nuclear magnetic resonance (“NMR”) apparatus made up of speci- *978 fled components including, among other things, a radio-frequency transmitter means for exciting a specimen by means of a train of radio-frequency pulses, successive ones which are in relative phase quadrature (i.e., off by 90°).

Claim 2 is dependent on Claim 1, and specifies that the transmitter means includes means for causing alternate pulses to be in phase opposition (i.e., off by 180°).

Claim 3 and claim 4 are method claims, which describe steps to be carried out when using the apparatus described in the first two claims. Claim 3 is the counterpart to Claim 1 and Claim 4 is the counterpart to Claim 2. See generally National Research Development Corporation v. Vanan Associates, 822 F.Supp. 1121, 1121-24 (D.N.J.1993) (discussing NMR spectrometry and the Hoult patent), af fd in part, vacated in part, 17 F.3d 1444 (Fed.Cir.1994) (Table) (text in Westlaw at 1994 WL 18963).

The primary defense asserted by Varían in this suit is their contention that, for a number of reasons, NRDC’s patent is invalid. All issues other than the validity and enforceability of the patent and Varian’s alleged infringement were bifurcated and stayed for a later separate trial.

Between February 9, and 23, 1993, this court held a bench trial. After trial, this court held that all four claims of the Hoult patent were not anticipated under 35 U.S.C. § 102(a) but were nevertheless invalid under the public use bar of 35 U.S.C. § 102(b). See NRDC, 822 F.Supp. at 1127-32. Because the court found all four claims of the patent invalid under § 102(b), none of Varian’s other defenses were addressed.

Plaintiff appealed this decision. The Federal Circuit upheld the determination that claims 1 and 3 were invalid under the public use bar of 35 U.S.C. § 102(b). See NRDC, 1994 WL 18963 at *3-*4. However, the Federal Circuit stated that it was undisputed that only the subject matter of claims 1 and 3 (and not claims 2 and 4) were incorporated into the apparatus that made up the prior public use — a spectrometer used by scientists at the Monsanto Company. Id. at *4. The Federal Circuit noted “that public use activity invalidating some claims of a patent under section 102(b) creates prior art that may support an obviousness-type invalidation of other claims within the same patent under §§ 102(b), 103.” Id. (citations omitted). Because none of the requisite factual findings which underlie an ultimate conclusion of obviousness were made by this court at trial, the Federal Circuit vacated this court’s holding with respect claims 2 and 4 and remanded the matter for further proceedings. See id. at *4^*5.

On remand, Varían argues, among other things, that claims 2 and 4 of the Hoult patent are invalid for three reasons: 1) due to obviousness under 35 U.S.C. § 103; 2) due to inequitable conduct before the Patent Office by NRDC; and 3) for failure to meet certain requirements of 35 U.S.C. § 112. NRDC denies that claims 2 and 4 are invalid, and asserts that Varían infringed claims 2 and 4.

On March 31, 1995, this court heard oral argument concerning these issues. The following constitutes my findings of fact and conclusions of law. As is detailed below, I will deny the remainder of NRDC’s claims against Varían because claims 2 and 4 of its patent are invalid pursuant to 35 U.S.C. § 103.

I. Findings of Fact. 2

A. The Background.

The patent in this case involves the field of nuclear magnetic resonance spectroscopy (“NMR”). Spectroscopy is the study and analysis of materials to determine their components and molecular structure. NMR is a particular form of spectroscopy that works by observing a material’s reaction to imposed radiation. NMR depends on the properties *979 of nuclear magnetism and operates on relatively low radio frequencies.

An NMR apparatus normally consists of a large magnet, a material to be analyzed, a radio-frequency pulse transmitter to excite a sample, and a radio-frequency receiver and detector, which will observe the response. In addition, a device such as a computer memory is attached to the detector to store the recorded data.

Modern spectroscopy uses a pulsed NMR method. Pursuant to this method, radiation is applied in short pulses rather than continuously, which was the prior method. As the nuclei in the sample being analyzed react, a transient, temporary radio-frequency response will follow. The transient is received by a probe. The probe is connected to a part of the receiver which is called the detector. The detector then produces a signal whose strength varies in precisely the same manner as the strength of the detected transient. Generally, the detected transient signals are printed or displayed as a spectrum of marks at frequencies characteristic of the material being analyzed.

In the mid-1960’s, Varían scientist Weston A. Anderson discovered a technology called Fourier transform NMR. This is a method of pulsed NMR in which the transmitter pulses excite the specimen by simultaneously producing a whole band of frequencies, covering the entire spectrum of possible frequencies. As the specimen responds to the various frequencies, a mathematical technique called Fourier transformation is used to translate the responses. The Fourier transformation method greatly increased the capabilities of NMR technology and the sensitivities of NMR apparatus.

The patent at issue in this case involves a technology called quadrature phase detection (“QPD”).

Initially, this means that the apparatus uses phase-sensitive detectors; that is, the transient signals received by the probe are combined with a reference signal in the receiver. In QPD, there are two phase-sensitive detectors, and the transient radio-frequency response splits into two parts. Each signal enters a “phase” and the resulting two signals are 90 degrees out of phase with each other (that is, they are in “relative phase quadrature”). The result, then, is two audio-frequency signals that come out correspondingly different, by an order of 90 degrees.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
883 F. Supp. 976, 1995 U.S. Dist. LEXIS 6151, 1995 WL 262830, Counsel Stack Legal Research, https://law.counselstack.com/opinion/national-research-development-corp-v-varian-associates-inc-njd-1995.